Clinical Features, Treatment Methods, and Evolution of Birdshot Chorioretinopathy in 5 Different Families

American Journal of Ophthalmology

Volumn 147, Issue 6, 2009, Pages

  Trinh, Liem ^a   Bodaghi, Bahram ^a   Fardeau, Christine ^a   Monin, Claire ^b   Labetoulle, Marc ^c   Soubrane, Gisèle ^d   Lehoang, Phuc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; HLA A29 ANTIGEN; HLA ANTIGEN; HLA B44 ANTIGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHORIORETINOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; ETHNIC GROUP; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PRIORITY JOURNAL; VITILIGINOUS CHORIORETINITIS;

EID: 67349119027     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.12.035     Document Type: Article

References (18)

1. Priem H.A., Kijlstra A., Noens L., et al. HLA typing in birdshot chorioretinopathy. Am J Ophthalmol 105 (1988) 182-185
2. LeHoang P., and Ryan S.J. Birdshot retinochoroidopathy. In: Pepose J.S., Holland G.N., and Wilhelmus K.R. (Eds). Ocular Infection and Immunity (1996), Mosby, St Louis, Missouri 570-578
3. Rothova A., Berendschot T.T., Probst K., et al. Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology 111 (2004) 954-959
4. Levinson R.D., and Gonzales C.R. Birdshot retinochoroidopathy: immunopathogenesis, evaluation, and treatment. Ophthalmol Clin N Am 15 (2002) 343-350
5. Levinson R.D., Brezin A., Rothova A., et al. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol 141 (2006) 185-187
6. Baarsma G.S., Priem H.A., and Kijlstra A. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res 9 (1990) S63-S68
7. LeHoang P., Ozdemir N., Benhamou A., et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol 113 (1992) 33-35
8. Levinson R.D., Rajalingam R., Park M.S., et al. Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol 138 (2004) 631-634
9. Szpak Y., Vieville J.C., Tabary T., et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A 98 (2001) 2572-2576
10. Fich M., and Rosenberg T. Birdshot retinochoroidopathy in monozygot twins. Acta Ophthalmol 70 (1992) 693-697
11. Ryan S.J., and Maumenee A.E. Birdshot retinochoroidopathy. Am J Ophthalmol 89 (1980) 31-45
12. Said-Nahal R., Miceli-Richard C., Berthelot J.M., et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Francais d'Etude Genetique des Spondylarthropathies. Arthritis Rheum 43 (2000) 1356-1365
13. Nishiyama M., Nakae K., Kuriyama T., et al. A study among related pairs of Japanese patients with familial Behçet's disease: group comparisons by interval of disease onsets. J Rheumatol 29 (2002) 743-747
14. Weisz J.M., Holland G.N., Roer L.N., et al. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in Southern California. Ophthalmology 102 (1995) 1012-1015
15. Levinson R.D., See R.F., Rajalingam R., et al. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol 65 (2004) 1477-1482
16. Rutzen A.R., Ortega-Larrocea G., Schwab I.R., et al. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 119 (1995) 239-240
17. Donvito B., Monnet D., Tabary T., et al. Different HLA class IA region complotypes for HLA-A29.2 and -A29.1 antigens, identical in birdshot retinochoroidopathy patients or healthy individuals. Invest Ophthalmol Vis Sci 46 (2005) 3227-3232
18. Shah K.H., Levinson R.D., Yu F., et al. Birdshot chorioretinopathy. Surv Ophthalmol 50 (2005) 519-541